Suppr超能文献

大鼠体内支链烷基聚乙氧基化表面活性剂的吸收与消除

Absorption and elimination of a branched-chain alkylpolyethoxylate surfactant in rats.

作者信息

Calvin G, Chasseaud L F, Down W H, Ballard S A, Hawkins D R

出版信息

Toxicol Lett. 1983 Sep;18(3):351-7. doi: 10.1016/0378-4274(83)90117-0.

Abstract

Oral doses (100 mg/kg/day) of a 14C-labelled branched-chain alkylpolyethoxylate [( C5H11]2CH14CH2O[CH2CH2O]6H; abbreviated [14C]A12E6) were extensively absorbed from the gastrointestinal tract of rats. During a multiple dosing regime, a proportion of 14C equivalent to one daily dose was excreted each day. This 14C was excreted in urine and faeces in equal proportions; less than 1% of the dose was expired as 14CO2. Almost all the faecal 14C came from the bile and had undergone enterohepatic circulation. After cutaneous application of [14C]A12E6 to rats (8 mg, 333 micrograms/cm2) under occluded conditions, about 25% of the dose was absorbed, mainly during the first 12 h. After dosing by both routes, the A12E6 was biotransformed to several metabolites that were more polar than the parent compound. Less than 15% of the dose was excreted unchanged.

摘要

给大鼠口服14C标记的支链烷基聚乙氧基化物([C5H11]2CH14CH2O[CH2CH2O]6H;缩写为[14C]A12E6)剂量为100毫克/千克/天,其从大鼠胃肠道被大量吸收。在多次给药方案期间,相当于一日剂量的一部分14C每天被排泄。这部分14C以相等比例经尿液和粪便排泄;不到1%的剂量以14CO2形式呼出。几乎所有粪便中的14C都来自胆汁并经历了肠肝循环。在封闭条件下给大鼠经皮施用[14C]A12E6(8毫克,333微克/平方厘米)后,约25%的剂量被吸收,主要在最初12小时内。经两种途径给药后,A12E6被生物转化为几种比母体化合物极性更强的代谢物。不到15%的剂量以原形排泄。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验